These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8195643)

  • 1. Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor.
    Ohmachi Y; Murata A; Matsuura N; Yasuda T; Uda K; Mori T
    Int J Pancreatol; 1994 Feb; 15(1):65-73. PubMed ID: 8195643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.
    Niinobu T; Ogawa M; Murata A; Nishijima J; Mori T
    J Exp Med; 1990 Oct; 172(4):1133-42. PubMed ID: 2170560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
    Kuramoto M; Yamashita J; Ogawa M
    Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
    Marks WH; Ohlsson K; Polling A
    Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells.
    Kawaguchi M; Hosotani R; Kogire M; Ida J; Doi R; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Masui T; Imamura M
    Int J Oncol; 2000 Jan; 16(1):37-41. PubMed ID: 10601546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic secretory trypsin inhibitor immunoreactivity detected in serum-free culture medium of human pancreatic carcinoma cell line, CAPAN-1.
    Ogata N; Murata A
    Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):233-44. PubMed ID: 3358013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of pancreatic secretory trypsin inhibitor in serum-free culture medium conditioned by the human pancreatic carcinoma cell line CAPAN-1.
    Ogata N
    J Biol Chem; 1988 Sep; 263(26):13427-31. PubMed ID: 3417664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of pancreatic secretory trypsin inhibitor gene in neoplastic tissues.
    Tomita N; Horii A; Yamamoto T; Ogawa M; Mori T; Matsubara K
    FEBS Lett; 1987 Dec; 225(1-2):113-9. PubMed ID: 2961612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution.
    Kuwata K; Hirota M; Shimizu H; Nakae M; Nishihara S; Takimoto A; Mitsushima K; Kikuchi N; Endo K; Inoue M; Ogawa M
    J Gastroenterol; 2002; 37(11):928-34. PubMed ID: 12483248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.
    Fujioka S; Sclabas GM; Schmidt C; Niu J; Frederick WA; Dong QG; Abbruzzese JL; Evans DB; Baker C; Chiao PJ
    Oncogene; 2003 Mar; 22(9):1365-70. PubMed ID: 12618762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma.
    Ohmachi Y; Murata A; Matsuura N; Yasuda T; Yasuda T; Monden M; Mori T; Ogawa M; Matsubara K
    Int J Cancer; 1993 Nov; 55(5):728-34. PubMed ID: 8244568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells.
    Freeman TC; Curry BJ; Calam J; Woodburn JR
    Gastroenterology; 1990 Nov; 99(5):1414-20. PubMed ID: 2210248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapancreatic origin of the pancreatic secretory trypsin inhibitor as an acute-phase reactant.
    Jönsson P; Linder C; Genell S; Ohlsson K
    Pancreas; 1996 Apr; 12(3):303-7. PubMed ID: 8830339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base variant of human pancreatic secretory trypsin inhibitor in healing of stress-induced gastric lesions in rats.
    Konturek PCh; Brzozowski T; Konturek SJ; Taut A; Pierzchalski P; Elia G; Pajdo R; Yagi S; Hahn EG
    Regul Pept; 1998 Oct; 77(1-3):95-103. PubMed ID: 9809802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of pancreatic secretory trypsin inhibitor expression in pulmonary adenocarcinoma: its possible participation in scar formation of the tumor tissues.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R; Matsuura N; Murata A; Tomita N; Monden T; Ogawa M
    Tumour Biol; 1992; 13(5-6):299-307. PubMed ID: 1290027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
    Marks WH; Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pancreatic secretory trypsin inhibitor (PSTI) produced in active form and secreted from Escherichia coli.
    Maywald F; Böldicke T; Gross G; Frank R; Blöcker H; Meyerhans A; Schwellnus K; Ebbers J; Bruns W; Reinhardt G
    Gene; 1988 Sep; 68(2):357-69. PubMed ID: 3065149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells.
    Kleeff J; Wildi S; Kumbasar A; Friess H; Lander AD; Korc M
    Pancreas; 1999 Oct; 19(3):281-8. PubMed ID: 10505759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study on pancreatic secretory trypsin inhibitor (PSTI) in gastric carcinomas.
    Higashiyama M; Monden T; Ogawa M; Matsuura N; Murotani M; Kawasaki Y; Tomita N; Murata A; Shimano T; Mori T
    Am J Clin Pathol; 1990 Jan; 93(1):8-13. PubMed ID: 2403744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
    Bloomston M; Shafii A; Zervos EE; Rosemurgy AS
    J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.